-
CRI Received a 100% ‘Four-Star Charity’ Rating – Here’s Why That Matters
When people seek out nonprofits with missions that align with their values, it can be initially challenging… -
Drs. Carl June and Michel Sadelain to Receive 2024 Breakthrough Prize in Life Sciences
CRI Scientific Advisory Council member Carl June, MD (University of Pennsylvania) and CRI Clinical Accelerator Advisor Michel… -
Cancer Cabinet Declares Updates to President Biden’s Cancer Moonshot Initiative
U.S. President Joe Biden’s administration is following through on last year’s commitment to reignite the White House… -
Recent Innovations and Challenges in Fighting Blood Cancers
The term “blood cancer” encompasses several types of cancer, including leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes (MDS),… -
Sarcomas: Unique Cancers that Merit Further Attention and Research
Sarcomas are unique compared to other types of cancer variations. In contrast to carcinomas, which arise from… -
Why Do We Get Cancer? How Our Lifestyles Impact Our Risk
There are many factors that dictate whether someone will develop cancer, and they fall roughly into two… -
Rising Female Talents in Cancer Immunotherapy Research
In recent years, there has been a renewed and welcomed focus on female scientists in STEM (science,… -
Love in the Lab: Valentine’s Day with the Doctors Delgoffe
CRI celebrates Valentine’s Day with immunologists Abby and Greg Delgoffe At first glance, one might not link… -
5 Things Patients, Caregivers, and Families Need to Know About Cancer
Our CEO speaks with Medium/Authority Magazine about cancer, immunotherapy, and how she became CEO of the world’s…
